Canagliflozin Alternatives in New York
Compare generic and therapeutic alternatives to Canagliflozin (canagliflozin) available at New York pharmacies. Save up to 48% on your prescription — no insurance required.
Top Alternatives in New York
Metformin
therapeutic
First-line T2D medication — dramatically cheaper
Avg cash price: $8/mo
Dapagliflozin (Farxiga)
therapeutic
Competing SGLT2 inhibitor with similar profile
Avg cash price: $530/mo
Empagliflozin (Jardiance)
therapeutic
SGLT2 inhibitor with strong cardiovascular outcomes data
Avg cash price: $560/mo
New York Prescription Assistance Programs
EPIC (Elderly Pharmaceutical Insurance Coverage)
Helps eligible New York seniors pay Medicare Part D premiums, deductibles, and co-pays. Also covers some medications not covered by Part D.
Eligibility: New York residents aged 65+ with income up to $75,000/year (single) or $100,000/year (married). Call 1-800-332-3742 to enroll.
New York Medicaid Rx
Comprehensive prescription drug coverage through New York's Medicaid managed care plans for eligible residents.
Eligibility: Low-income New York adults up to 138% FPL, children, pregnant women, seniors, and people with disabilities.
Frequently Asked Questions
Is there a generic for canagliflozin (Invokana)?
Not yet as of 2025. Canagliflozin is still under brand exclusivity as Invokana. All SGLT2 inhibitors remain brand-only at similar high prices.
How does canagliflozin compare to other SGLT2 inhibitors?
Canagliflozin, dapagliflozin, and empagliflozin have similar glucose-lowering effects. Differences emerge in cardiovascular and renal outcomes data — your cardiologist or endocrinologist guides the choice.
What is the main risk specific to canagliflozin?
Canagliflozin carries an FDA warning about increased risk of lower-limb amputations, particularly in patients with peripheral vascular disease. Discuss your individual risk with your doctor.
Can Script Unlock help with canagliflozin costs?
While there is no generic, Script Unlock pharmacies sometimes offer lower cash-pay brand pricing. It is worth posting your script to compare bids.
Is metformin a good alternative to canagliflozin for T2D?
Metformin is first-line T2D therapy at under $10/month. SGLT2 inhibitors like canagliflozin are added for patients who need additional cardiovascular or renal benefits beyond glucose lowering.